Compounds > alanine

alanine and n-(2-(mercaptomethyl)-3-phenylbutanoyl)-l-alanine

alanine has been researched along with n-(2-(mercaptomethyl)-3-phenylbutanoyl)-l-alanine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fournié-Zaluski, MC; Gonzalez Vera, W; Laboulandine, I; Michel, JB; Pham, I; Roques, BP1
Barbe, B; Coric, P; Fournié-Zaluski, MC; Gonzalez, W; Jullian, N; Michel, JB; Pham, I; Roques, BP; Rousselet, N; Turcaud, S1
Fournié-Zaluski, MC; Gonzalez, W; Michel, JB; Pham, I; Roques, BP; Turcaud, S1
Beslot, F; Fournié-Zaluski, MC; Gonzalez, W; Laboulandine, I; Michel, JB; Roques, BP1

Other Studies

4 other study(ies) available for alanine and n-(2-(mercaptomethyl)-3-phenylbutanoyl)-l-alanine

ArticleYear
Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 272, Issue:1

    Topics: Alanine; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Bradykinin; Dose-Response Relationship, Drug; Male; Natriuresis; Neprilysin; Rats; Rats, Inbred SHR; Rats, Wistar; Renin

1995
New dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme: rational design, bioavailability, and pharmacological responses in experimental hypertension.
    Journal of medicinal chemistry, 1994, Apr-15, Volume: 37, Issue:8

    Topics: Alanine; Amino Acid Sequence; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Biological Availability; Diuresis; Humans; Kidney; Lung; Male; Mice; Models, Molecular; Molecular Sequence Data; Molecular Structure; Natriuresis; Neprilysin; Prodrugs; Rabbits; Rats; Rats, Inbred SHR; Recombinant Proteins; Stereoisomerism

1994
Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension.
    Proceedings of the National Academy of Sciences of the United States of America, 1994, Apr-26, Volume: 91, Issue:9

    Topics: Administration, Oral; Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Diuresis; Dose-Response Relationship, Drug; Hypertension; Male; Natriuresis; Neprilysin; Prodrugs; Rats; Rats, Inbred SHR; Rats, Wistar; Stereoisomerism

1994
Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 278, Issue:2

    Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Disease Models, Animal; Male; Myocardial Infarction; Neprilysin; Peptidyl-Dipeptidase A; Rats; Rats, Wistar

1996